ENTITY

Adaptimmune Therapeutics (ADAP US)

3
Analysis
Health CareUnited States
Adaptimmune Therapeutics plc is a clinical-stage biopharmaceutical company. The Company develops novel cancer immunotherapy products based on T-cell receptor platform that helps to identify cancer targets. Adaptimmune Therapeutics serves customers worldwide.
more
Refresh
Company Event06 Nov 2024 21:00 • Upcoming
Add To Calendar
Company Event12 Aug 2024 20:00 • Latest
Company Event31 May 2024 20:00
Company Event15 May 2024 20:00
x